Pay in 4 interest-free payments of $5.72 Learn more
Ships within 48 hours · Estimated delivery Aug 13 - Aug 18
Pfeifer KJ, Selzer A, Whinney CM, Rogers B, Naik AS, Regan D, et al
This design enables three distinct pharmacological actions in a single molecule: GLP-1 receptor agonism : The two conjugated GLP-1 analog peptides activate GLP-1R to produce appetite suppression, glucose-dependent insulin secretion, glucagon suppression, and delayed gastric emptying GIP receptor antagonism : The antibody component blocks GIP signaling, which may reduce fat storage and modify energy metabolism Extended half-life : The antibody backbone provides a half-life of approximately 21 days -- three times longer than any approved weekly incretin therapy -- enabling once-monthly dosing The GIP antagonism approach is the most distinctive feature
Gupta YK, Ramachandran SS
Like methylcellulose, it is non-fermentable, meaning no gas or bloating
Every week of adequate collagen protein, resistance training, and calcium intake is a week your bones have the building materials they need
Legal status: Lipo-C is a compounded medication, meaning it's mixed by pharmacies according to specific formulations rather than manufactured as a standardized pharmaceutical product
